| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJM200008173430703 |
| P698 | PubMed publication ID | 10944563 |
| P2093 | author name string | Salazar-Lindo E | |
| Gutierrez M | |||
| Chea-Woo E | |||
| Santisteban-Ponce J | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | diarrhea | Q40878 |
| P304 | page(s) | 463-467 | |
| P577 | publication date | 2000-08-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Racecadotril in the treatment of acute watery diarrhea in children | |
| P478 | volume | 343 |
| Q44613149 | A Phase I Study of Irinotecan As a 3-Week Schedule in Children With Refractory or Recurrent Solid Tumors |
| Q38015827 | A comprehensive review of the pharmacodynamics, pharmacokinetics, and clinical effects of the neutral endopeptidase inhibitor racecadotril |
| Q40718634 | ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults |
| Q37332138 | Acute infectious diarrhea in children |
| Q37156841 | Acute infectious diarrhoea in children: new insights in antisecretory treatment with racecadotril |
| Q36904890 | Acute infectious pediatric gastroenteritis: beyond oral rehydration therapy |
| Q36078760 | Alvimopan, a selective peripherally acting mu-opioid antagonist |
| Q39282190 | Analysis of factors influencing the overall effect of racecadotril on childhood acute diarrhea. Results from a real-world and post-authorization surveillance study in Venezuela |
| Q42285619 | Anti-rotavirus protein reduces stool output in infants with diarrhea: a randomized placebo-controlled trial |
| Q36478086 | Antisecretory drugs for diarrheal disease |
| Q26766058 | Calcium-sensing receptor: A new target for therapy of diarrhea |
| Q33777945 | Clostridium difficile colonization in early infancy is accompanied by changes in intestinal microbiota composition |
| Q51733696 | Cost utility, budget impact, and scenario analysis of racecadotril in addition to oral rehydration for acute diarrhea in children in Malaysia. |
| Q36505498 | Current and future developments in travelers' diarrhea therapy |
| Q34669470 | Dehydration in acute gastroenteritis |
| Q92061410 | Diarreas agudas del niño |
| Q35677370 | Diarrhoea in children: an interface between developing and developed countries. |
| Q91908296 | Diarrhées aiguës de l’enfant |
| Q31095889 | Drug treatment of acute infectious diarrhea in infants and children |
| Q28250954 | Effect of nitazoxanide for treatment of severe rotavirus diarrhoea: randomised double-blind placebo-controlled trial |
| Q44121498 | Effect of racecadotril in the management of acute diarrhea in infants and children |
| Q40256152 | Effects of Racecadotril on Weight Loss and Diarrhea Due to Human Rotavirus in Neonatal Gnotobiotic Pigs (Sus scrofa domesticus). |
| Q41806934 | Efficacy and tolerability of racecadotril in the treatment of cholera in adults: a double blind, randomised, controlled clinical trial |
| Q34692479 | Enteric nerves and diarrhoea |
| Q35939258 | Evaluating the cost utility of racecadotril for the treatment of acute watery diarrhea in children: the RAWD model |
| Q34987675 | Expert review of the evidence base for self-therapy of travelers' diarrhea |
| Q48130881 | Gelatin Tannate for Acute Childhood Gastroenteritis: A Randomized, Single-Blind Controlled Trial |
| Q35180006 | Getting control of intestinal secretion: thoughts for 2003. |
| Q91600069 | Guideline for the Antibiotic Use in Acute Gastroenteritis |
| Q34566913 | Hypersensitivity to racecadotril: a case report. |
| Q91901559 | I, 1.Viral causes of gastroenteritis |
| Q91901569 | I, 3. The enteric nervous system and infectious diarrhea |
| Q91901574 | I, 5. Treatment of viral gastroenteritis |
| Q36586589 | Impact of clinically tested NEP/ACE inhibitors on tumor uptake of [(111)In-DOTA]MG11-first estimates for clinical translation |
| Q40197032 | Impact of rotavirus vaccine introduction on rotavirus-associated seizures and a related possible mechanism |
| Q28731510 | In vitro neutralisation of rotavirus infection by two broadly specific recombinant monovalent llama-derived antibody fragments |
| Q37843682 | Infectious diarrhea: Cellular and molecular mechanisms |
| Q37998313 | Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain |
| Q34331554 | Interactions between rotavirus and gastrointestinal cells |
| Q93486487 | Le traitement de la diarrhée |
| Q35598312 | Management of infectious diarrhoea |
| Q27004496 | Management strategies in the treatment of neonatal and pediatric gastroenteritis |
| Q46930970 | Medication in infectious acute diarrhea in children |
| Q34304499 | Microbes and microbial toxins: paradigms for microbial-mucosal interactions. VIII. Pathological consequences of rotavirus infection and its enterotoxin |
| Q45896255 | New-generation treatment? Targeted antiviral therapy for rotavirus |
| Q79863382 | Nitazoxanide for rotavirus diarrhoea? |
| Q35814445 | Novel agents for the control of secretory diarrhoea |
| Q34600968 | Novel targets for the control of secretory diarrhoea |
| Q48327638 | Ontogeny, regional and cellular distribution of the novel metalloprotease neprilysin 2 in the rat: a comparison with neprilysin and endothelin-converting enzyme-1 |
| Q35185222 | Opioid receptors in the gastrointestinal tract |
| Q55491449 | Oral administration of tannins and flavonoids in children with acute diarrhea: a pilot, randomized, control-case study. |
| Q36852574 | Pharmacologic Comparison of Clinical Neutral Endopeptidase Inhibitors in a Rat Model of Acute Secretory Diarrhea |
| Q35045783 | Pharmacological characterization of a 7-benzylidenenaltrexone-preferring opioid receptor in porcine ileal submucosa |
| Q34616273 | Prevention and treatment of viral diarrhea in pediatrics |
| Q43245166 | Prospective randomized double-blind trial of racecadotril compared with loperamide in elderly people with gastroenteritis living in nursing homes |
| Q41172210 | Racecadotril : A Novel Antidiarrheal |
| Q92138672 | Racecadotril for acute diarrhoea in children |
| Q26771657 | Racecadotril for acute diarrhoea in children: systematic review and meta-analyses |
| Q37598047 | Racecadotril for the treatment of severe acute watery diarrhoea in children admitted to a tertiary hospital in Kenya |
| Q54271858 | Racecadotril in the treatment of acute diarrhea in children: a systematic, comprehensive review and meta-analysis of randomized controlled trials. |
| Q35087885 | Racecadotril versus loperamide: antidiarrheal research revisited |
| Q36093331 | Recent advances in small bowel diseases: Part I. |
| Q52632865 | Role of Ca2+ homeostasis disruption in rotavirus-associated seizures. |
| Q43223298 | Role of antidiarrhoeal drugs as adjunctive therapies for acute diarrhoea in children. |
| Q26996393 | Rotaviruses |
| Q43004987 | Serotonin and vasoactive intestinal peptide antagonists attenuate rotavirus diarrhoea |
| Q35616704 | Severe acute diarrhea |
| Q41096117 | The cost utility and budget impact of adjuvant racecadotril for acute diarrhea in children in Thailand |
| Q38159241 | Translating molecular physiology of intestinal transport into pharmacologic treatment of diarrhea: stimulation of Na+ absorption |
| Q35077290 | Travellers' diarrhoea |
| Q43816041 | Treating travelers' diarrhea. When should medication be given? |
| Q82284780 | Treatment of diarrheal disease |
| Q34180145 | Treatment of infectious diarrhea in children |
| Q28284578 | Treatment of opioid-induced gut dysfunction |
| Q39410276 | Update on Traveler's Diarrhea |
| Q59356442 | Viral gastroenteritis |
| Q91909624 | Viral gastroenteritis |
| Q93238844 | Viral gastroenteritis: Causes, pathophysiology, immunology, treatment, and epidemiology |
Search more.